International Journal of Tuberculosis and Lung Disease

Article	Citations
TB infection in adults with diabetes mellitus in Uganda	217
Clinical profile and outcomes of paediatric central nervous system tuberculomas	115
TB-related deaths among adults in Guinea-Bissau	94
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease	62
Launch of a second wave of IJTLD Clinical Standards for Lung Health	46
The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB	42
Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?	36
Dr Christopher Zishiri	35
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB	35
Latent TB and depressive symptoms in household contacts of persons with active TB	28
The impact of sputum quality on Xpert positivity in active case-finding for TB	26
TB in ageing populations: lessons from Japan and Korea	26
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo	25
Screening of refugees from Ukraine for TB: a TBnet survey	25
WHO target product profiles for TB preventive treatment	24
Reply to ‘Estimating TB survival ‐ mind the immortal-time gap’	23
Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients	22
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs	21
The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya	21
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	20
Cost-effectiveness of pretomanid-based regimen for highly drug- resistant TB in a low-burden setting	18
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	18
The COVID-19 pandemic does not bode well for TB control	17
Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting	16
Haematological indicators of mortality in people with community-acquired pneumonia living at high altitude	16

Are schools prepared to manage students with an asthma attack?	15
Reply to: Observations on malnutrition and anti-TB drugs in Ghana	15
Assessment of TB patient cost – what about the mitigation strategy?	15
Literature Highlights	15
Perceived stigma among people with TB and household contacts	14
Performance of spirometry assessment at TB diagnosis	14
Assessing patient satisfaction with video-supported therapy for drug-susceptible TB treatment	13
TB testing in HIV-positive patients prior to antiretroviral treatment	13
Gender differences in health-seeking behaviour, diagnosis and treatment for TB	13
Impact of revised definitions for extensively drug-resistant TB on disease classification	13
Accessibility and TB patient satisfaction in Nigeria	13
Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria	12
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	12
Occupational transmission of TB infection during autopsy	12
Sputum culture conversion definitions and analytic practices for multidrug-resistant TB	12
Standards for clinical trials for treating TB	12
Prevalence of chronic airflow obstruction in sub-Saharan Africa	11
TB disease yield from household contact screening of TB index patients in Pakistan	11
A cohort study exploring variables associated with mortality in critically ill TB patients	11
Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in multidrug-resistant TB	11
Clinical standards for the diagnosis and management of asthma in low- and middle-income countries	11
Higher yield using an event-based vs. door-to-door approach for active case-finding for TB	10
Impact of COVID-19 on TB services in Korea	10
Risk factors for severe COPD exacerbation in Chinese adults	10
Factors associated with false-negative for T-SPOT.TB in patients with TB disease	10
Opportunities to prevent and manage undernutrition to amplify efforts to end TB	10
Patterns of TB transmission in the United States, 2011–2017	10
Emphasis on post-TB lung disease and other sequelae of TB is good but a public health approach to TB is morally ambitious	9
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis	9
Post-TB lung disease: keep going beyond TB!	9
Does distance to healthcare facility affect care-seeking for TB-related symptoms in Tanzania?	9
Facilitators and barriers to adolescent participation in a TB clinical trial	9
Paediatric TB care in the United Kingdom	9
A novel method for contact tracing for TB at household and community level	9
Health status of Italian children living close to cultivations sprayed with pesticides	8
Population attributable fraction for smoking and diabetes in TB	8
Epidemiology and clinical characteristics of childhood TB identified using active and passive case finding	8
EJ-antisynthetase syndrome presenting as severe acute respiratory distress syndrome	8
Impact of COVID-19 on extrapulmonary TB and the benefit of decentralised TB services	8
TB case fatality and recurrence in a private sector cohort in Mumbai, India	8
Updated guidelines for child and adolescent TB	8
Initial experience with BPaL-based regimens to treat multidrug-resistant TB	8
Bedaquiline-based all-oral regimen for macrolide-resistant Mycobacterium abscessus pulmonary disease	7
Meeting of two pandemics in prison: a challenging event in a challenging environment	7
TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine	7
Population pharmacokinetics of bedaquiline in patients with drug-resistant TB	7
If you want to go far, go together: standardisation and data sharing in TB drug development	7
Cascade of care for people with TB and diabetes in India	7
Medical management of large and multiple pulmonary echinococcal cysts	7
Protecting healthcare workers from TB	7

Clinical features, microbiology and lung function in post-TB bronchiectasis compared to other aetiologies	7
Evaluation of QFT-Plus performance using blood samples stored at room temperature	7
Use of computed tomography for the diagnosis of TB during a paediatric outbreak	7
Perceived stigma related to TB preventive therapy	7
Post-hospitalisation respiratory and physical functions in patients with SARS-CoV-2 delta	7
Contribution of Xpert® MTB/RIF to pediatric TB diagnosis in Mozambique	7
The effect of systematic screening of the general population on TB case notification rates	7
Cost of TB prevention and treatment in the Philippines in 2017	6
Mortality and causes of death in non-tuberculous mycobacterial pulmonary disease	6
Lower TB notification rates in later life in the same birth cohort, Japan, 1950–2020	6
Predictors of TB disease in HIV-exposed children from Southern Africa	6
TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil	6
A scoping review of interventions to mitigate common non-communicable diseases among people with TB	6
Supplementary inspired oxygen fraction is a simple clinical tool that predicts clinical deterioration	6
Characteristics, risk factors and outcomes of critically ill patients with active TB	6
The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia	6
Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan	6
Community-based intervention and health education to scale up TB preventive treatment for children	6
Clinical experience of TB in patients treated with anti-TNF-α	6
Paediatric formulations for the treatment of drug resistant TB: closing the gaps	6
Prevalence and determinants of chronic respiratory diseases in adults in rural Sudan	6
Rifampicin-resistant TB: discordance between Xpert® MTB/RIF and MTBDRplus results	6
The high costs facing TB-affected households in Mali	6
Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB	6
Financial impact of COVID-19 on TB patients in India	6
An approach for improving the quality of country-level TB modelling	6
TB notifications among citizens and non-citizens in Taiwan	6
Towards quality adolescent-friendly services in TB care	6
Real-world implementation of video-observed therapy in an urban TB program in the United States	6
Effect of biological therapies on TB treatment outcomes	6
Urine LAM diagnostics can close the deadly testing gap for TB	6
TB and chronic pulmonary aspergillosis: a few relevant points	6
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities	6
Estimating TB survival ‐ mind the immortal-time gap	5
Cutaneous adverse drug reactions to fixed-dose combination treatments for TB	5
A new understanding of clinical patterns in post-TB lung disease	5
Time to integrate epidemiological and economic models for TB	5
High prevalence of multidrug-resistant TB among household contacts in a high burden setting	5
Chronic pulmonary aspergillosis as a sequel to pulmonary TB	5
Use of stool swabs in molecular transport media increases access to Xpert Ultra testing for TB in children	5
Sputum pooling for rapid and cost-effective active case-finding for TB in prisons	5
Bronchiectasis exacerbations: certainties and future challenges	5
Population attributable fraction for undernutrition due to TB does not take account of bidirectional causality	5
TB disease in children from the prehistoric era	5
Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB	5
Extemporaneously compounded liquid formulations of clofazimine	5
Rapid molecular diagnostics to detect resistance to second-line anti-TB drugs	5
Fluoroquinolone preventive therapy for children exposed to MDR-TB	5
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs	5
Glutathione and N-acetylcysteine in TB management	5
TB and COVID-19 co-infection in a pulmonology hospital	5
Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing	5
Impact of COVID-19 on hospitalisations for asthma	5
Responding to the post-pandemic crisis: post-exposure prophylaxis for TB	5
Diabetes characteristics and long-term management needs in diabetic TB patients	5
TB mortality in low-incidence countries: can we reduce it further?	5
National approaches to TB care in adolescents	5
Determinants of treatment outcomes in patients with multidrug-resistant TB	5
TB screening of Ukrainian refugees in Germany	5
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB	4
Factors associated with presenting to private sector care providers at the onset of TB symptoms	4
Dactylitis due to accidental needle-stick injury with a BCG-loaded syringe	4
Quality assessment of clinical practice guidelines for the management of wheezing disorders in children	4
New diagnostics for the spectrum of asymptomatic TB: from infection to subclinical disease	4
TB screening, prevention and treatment cascade in a Malawi prison	4
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	4
Diabetes mellitus and TB – finding strategies to reduce the double burden of disease	4
Early mortality during rifampicin-resistant TB treatment	4
Metabolic characterisation of adult Ugandan patients with TB and diabetes mellitus comorbidity	4
A study of persistent symptoms and pulmonary function at 3 months post moderate or severe COVID-19 in Angola	4
Early line-probe assay using DNA specimens in patients with pulmonary TB	4
After DOT, the brave new world?	4
Family directly observed therapy for children with drug-resistant TB	4
An epidemiological analysis of TB trends in native and migrant populations, New Mexico, 1993–2021	4
Establishing proof of concept for utility of Trueprep®-extracted DNA in line-probe assay testing	4
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	4
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts	4
Geographical differences in chronic obstructive pulmonary disease mortality trends by sex, Spain, 1980–2021	4
A bold new future for the IJTLD	4
Efflux pump gene expression study using RNA-seq in multidrug-resistant TB	4

WHO drug-resistant TB guidelines 2022: what is new?	4
A home-based care programme for rifampicin-resistant TB	4
Literature Highlights	4
Implementation of modified, all-oral shorter TB regimens in Armenia	4
TB screening of children from Ukraine in Germany	4
Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial	4
Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB	4
Outcomes for people with TB by disease severity at presentation	3
Concomitant pulmonary disease is common among patients with extrapulmonary TB	3
Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013–2020	3
Eosinophils in bronchiectasis: searching for a new endotype	3
Factors associated with patient delay in the diagnosis of TB – a study of health-seeking behaviour	3
Launch of the IJTLD Clinical Standards for Lung Health	3
Attrition in the treatment cascade among elderly patients with multidrug-resistant TB	3
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	3
Outcomes of TB contact tracing and predictors of success: a 10-year retrospective cohort analysis in Birmingham, UK	3
Stool-based Xpert testing for diagnosis of TB in children and critically ill adults	3
TB and interstitial lung disease: a systematic review and meta-analysis	3
The 100th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19	3
Isolation and purification of lipoarabinomannan from urine of adults with active TB	3
Poor dietary intake at hospital admission is a predictor of mortality in patients with COVID-19	3
Time to care-seeking for TB symptoms	3
Work-related interstitial lung diseases: reassessing the burden	3
SMaRT-PCR: sampling using masks and RT-PCR, a non-invasive diagnostic tool for paediatric pulmonary TB	3
Therapeutic drug monitoring for isoniazid and rifampicin exposure	3
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	3
Contribution of post-infectious bronchiolitis obliterans to non-cystic fibrosis bronchiectasis in children	3
Use of rapid molecular TB diagnostics for incarcerated people in Brazil	3
Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting	3
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	3
Evaluation of the MolecuTech® REBA MTB-XMDR kit for detection of pre-extensively drug-resistant TB	3
Interventions to enhance treatment adherence and retention in care for HIV-TB	3
Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae	3
Introduction of new drugs for drug-resistant TB in Iraq	3
Culture-negative TB: clinical characteristics, risk factors and treatment outcomes	3
Clinical outcomes in comorbid COVID-19 and TB cases	3
Preventive treatment for MDR-TB exposure in households	3
TB in older people in Asia: why it is important	3
The economic burden of TB-affected households in DR Congo	3
Factors associated with referrals for directly observed treatment and unsuccessful treatment	3
Identifying gaps in the cascade of care for latent TB infection in a low-incidence setting	3
Factors associated with screening failure and study withdrawal in multidrug-resistant TB	3
Nosocomial TB in two neonatal intensive care units at a tertiary care centre: infection risk and outcomes	3
Highlighting the characteristics of TB disease in older people	3
Recent developments in the diagnosis and treatment of extrapulmonary non-tuberculous mycobacterial diseases	3
Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field	3
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study	3
Bridging the gap: key evidence needed to strengthen global policies to end TB	3
Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?	3
Impact of the COVID-19 pandemic on TB infection testing	3
Risk factors for the isolation of Haemophilus influenzae in patients with stable chronic obstructive pulmonary disease	3
Post-TB bronchiectasis: clinical characteristics and microbiology	3
First report of multidrug-resistant M. tuberculosis Beijing strain isolated from the indigenous population in Tunisia	3
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients	3
A comprehensive person-centred TB care model, from malnutrition to mental health	3
Prevalence and determinants of chronic respiratory diseases in adults in Sudan	3
Outcomes of childhood TB in countries with a universal BCG vaccination policy	3
The effect of TB patient delay on loss to follow-up in Portugal	3
The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV	3
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	3
Predictive value of neutrophil-to-lymphocyte ratio in severe pulmonary infection: sex-specific cut-off values needed	3
Programmatic implications of a sub-national TB prevalence survey in India	3